Susan Jaffe | Washington Correspondent for The Lancet | 13th January 2016
No single federal agency reviews US drug prices, but 51 members of the U. S. House of Representatives have discovered a 35-year-old law that allows the governme
nt to control huge hikes in drug costs. And they want the Department of Health and Human Services and National Institutes of Health (HHS) to use it. Earlier this week the group led by Texas Democrat Lloyd Doggett wrote to HHS Secretary Sylvia Matthews Burwell and NIH director Dr. Francis Collins to explain why. [Continued here]…